SYMPHONY-PE Study for Treatment of Pulmonary Embolism

NACompletedINTERVENTIONAL
Enrollment

109

Participants

Timeline

Start Date

December 13, 2023

Primary Completion Date

May 4, 2025

Study Completion Date

May 29, 2025

Conditions
Acute Pulmonary EmbolismThromboembolismEmboli, PulmonaryThrombosisThrombus; EmbolismEmbolismCardiovascular DiseasesVascular Diseases
Interventions
DEVICE

Symphony Thrombectomy System

The Symphony Thrombectomy System will be used to restore blood flow to the pulmonary arteries by removing thrombus/embolus/clot using aspiration and mechanical clot engagement.

Trial Locations (19)

10016

NYU Grossman School of Medicine, New York

10029

Icahn School of Medicine at Mount Sinai, New York

10549

Northwell Health, Mount Kisco

23507

Sentara Norfolk General Hospital, Norfolk

29605

Prisma Health, Greenville

30322

Emory University, Atlanta

32256

First Coast Cardiovascular Institute, Jacksonville

32308

Tallahassee Memorial Hospital, Tallahassee

35801

Huntsville Hospital, Huntsville

45237

Bon Secours Mercy Health, Inc, Cincinnati

46202

Indiana University, Indianapolis

48073

William Beaumont Hospital - Royal Oak, Royal Oak

48236

Ascension St John Hospital, Detroit

49503

Corewell Health, Grand Rapids

60026

Endeavor Health, Glenview

75093

The Heart Hospital Baylor Plano, Plano

75230

Medical City Dallas Hospital, Dallas

76104

Medical City Fort Worth Hospital, Fort Worth

90048

Cedars-Sinai Medical Center, Los Angeles

Sponsors
All Listed Sponsors
lead

Imperative Care, Inc.

INDUSTRY

NCT06062329 - SYMPHONY-PE Study for Treatment of Pulmonary Embolism | Biotech Hunter | Biotech Hunter